AWAKN-P001 Is a N-methyl-D-aspartate Receptor-Modulating Drug Used in Combination with Psycho-Social Support for The Treatment of Severe Alcohol Use Disorder...
Many experts have been predicting some big mergers and acquisitions in the psychedelic industry. Well, it looks like they were spot on. This week has...
Ketamine clinic company Braxia Scientific Corp. (CSE: BRAX) (OTC Pink: BRAXF) announced the filing of its unaudited financial statements for the fiscal...
The companies say they will have the most substantial dataset on the DMT molecule in the industry and largest IP portfolio The post Cybin inks agreement...
In big breaking news, Cybin has signed a deal to acquire Small Pharma, giving Cybin an advanced DMT trial. The post Breaking News: Cybin to Acquire...
VANCOUVER, British Columbia, Aug. 25, 2023 (GLOBE NEWSWIRE) — MindBio Therapeutics (CSE:MBIO) (FSE:WF6), an Australia-based... The post InvestmentPitch...
The psychedelic industry is changing and growing rapidly. Psychedelic medicines are being catapulted into the mainstream, and these top 10 psychedelic...
The brain health brand took in its first institutional capital with plans to go into over 1,800 retail stores in the next year.
Psychedelics are creating an alternative form of healthcare, so it is only reasonable that the industry would seek out alternative sources of funding....
founders must confront a key question: Are there too many accelerators now, and is joining an accelerator even needed anymore?